Trials / Sponsors / C. Babis Andreadis
C. Babis Andreadis
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma | Phase 1 | 2020-09-11 |
| Terminated | Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2015-05-01 |
| Completed | Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in Diffuse Large Cell Lymphoma Relapsed/Refractory | Phase 2 | 2012-05-25 |